These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 31802437)

  • 1. All that a physician should know about FODMAPs.
    Mehtab W; Agarwal A; Singh N; Malhotra A; Makharia GK
    Indian J Gastroenterol; 2019 Oct; 38(5):378-390. PubMed ID: 31802437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to institute the low-FODMAP diet.
    Barrett JS
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():8-10. PubMed ID: 28244669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of the low FODMAP diet.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice.
    Whelan K; Martin LD; Staudacher HM; Lomer MCE
    J Hum Nutr Diet; 2018 Apr; 31(2):239-255. PubMed ID: 29336079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome.
    Hewawasam SP; Iacovou M; Muir JG; Gibson PR
    J Gastroenterol Hepatol; 2018 Feb; 33(2):365-374. PubMed ID: 28700090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-challenging FODMAPs: the low FODMAP diet phase two.
    Tuck C; Barrett J
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():11-15. PubMed ID: 28244664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FODMAPs in irritable bowel syndrome.
    Shepherd SJ; Halmos E; Glance S
    Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):605-9. PubMed ID: 25255126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.
    Van den Houte K; Colomier E; Routhiaux K; Mariën Z; Schol J; Van den Bergh J; Vanderstappen J; Pauwels N; Joos A; Arts J; Caenepeel P; De Clerck F; Matthys C; Meulemans A; Jones M; Vanuytsel T; Carbone F; Tack J
    Gastroenterology; 2024 Jul; 167(2):333-342. PubMed ID: 38401741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
    Staudacher HM; Whelan K; Irving PM; Lomer MC
    J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FODMAPs: food composition, defining cutoff values and international application.
    Varney J; Barrett J; Scarlata K; Catsos P; Gibson PR; Muir JG
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():53-61. PubMed ID: 28244665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
    Liu J; Chey WD; Haller E; Eswaran S
    Annu Rev Med; 2020 Jan; 71():303-314. PubMed ID: 31986083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
    Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
    J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
    Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.
    Krogsgaard LR; Lyngesen M; Bytzer P
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1506-1513. PubMed ID: 28440580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food regulations: low FODMAP labeling and communication goals.
    Méance S; Giordano J; Chuang E; Schneider H
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():62-63. PubMed ID: 28244659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
    Erickson J; Korczak R; Wang Q; Slavin J
    Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FODMAPs in Patients With Irritable Bowel Syndrome.
    Mansueto P; Seidita A; D'Alcamo A; Carroccio A
    Nutr Clin Pract; 2015 Oct; 30(5):665-82. PubMed ID: 25694210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
    Nordin E; Brunius C; Landberg R; Hellström PM
    Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.